论文部分内容阅读
目的 观察丽科伟对急性呼吸道病毒感染小儿的疗效。 方法 随机将符合标准的病例分为治疗组 ( 5 0例 )和对照组 ( 30例 ) ,治疗组用丽科伟 ,对照组不用任何抗病毒药 ,其他治疗方法相同。 结果 治疗组痊愈 2 3例 ( 4 6 % ) ,显效 15例 ( 30 % ) ,有效 10例 ( 2 0 % ) ,无效 2例 940 % ) ,总有效率 76 %。对照组痊愈 12例 ( 4 0 % ) ,显效 2 7例 ( 2 3 3% ) ,有效 5例 ( 16 7% ) ,无效 6例( 2 0 % ) ,总有效率为 6 3 3 %。 结论 丽科伟是一种疗效良好 ,安全性高的治疗呼吸道病毒感染药物
Objective To observe the effect of Li Kewei on children with acute respiratory virus infection. Methods The patients were randomly divided into treatment group (50 cases) and control group (30 cases). The treatment group was treated with Recovir and the control group without any antiviral drugs. The other treatments were the same. Results The treatment group cured 23 cases (46%), markedly effective in 15 cases (30%), effective in 10 cases (20%), invalid in 2 cases (940%), the total effective rate was 76%. The control group was cured in 12 cases (40%), effective in 27 cases (23.3%), effective in 5 cases (16.7%), ineffective in 6 cases (20%), the total effective rate was 63.3%. Conclusion Li Ke Wei is a good effect, high safety of the treatment of respiratory virus infection drugs